IGF1R and c-met as therapeutic targets for colorectal cancer

被引：37
作者：
Shali, Hajar [1 ,2 ]
Ahmadi, Majid [3 ,4 ]
Kafil, Hossein Samadi [5 ]
Dorosti, Abbasali [6 ]
Yousefi, Mehdi [3 ,4 ]
机构：
[1] Tabriz Univ Med Sci, Liver & Gastrointestinal Dis Res Ctr, Tabriz, Iran
[2] Tabriz Univ Med Sci, Students Res Comm, Tabriz, Iran
[3] Tabriz Univ Med Sci, Immunol Res Ctr, Tabriz, Iran
[4] Tabriz Univ Med Sci, Sch Med, Dept Immunol, Tabriz, Iran
[5] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
[6] Tabriz Univ Med Sci, Imam Reza Hosp, Sch Med, Dept Anesthesiol, Tabriz, Iran
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2016年 / 82卷
关键词：
Colorectal cancer; IGF1R; c-Met; Receptor tyrosine kinase; GROWTH-FACTOR-I; MONOCLONAL-ANTIBODY FIGITUMUMAB; FACTOR SIGNALING PATHWAY; FACTOR-BINDING-PROTEINS; INHIBITS TUMOR-GROWTH; FACTOR RECEPTOR; TYROSINE KINASE; COLON-CANCER; CARCINOMA CELLS; MEDIATED MIGRATION;
D O I：
10.1016/j.biopha.2016.05.034
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The type 1 IGF receptor (IGF1R) and mesenchymal-epithelial transition (MET) are hetrodimeric and transmembrane receptor tyrosine kinases, which are frequently overexpressed by several tumor types, including colorectal cancer (CRC). These receptors bind to their specific ligands, insulin growth factors (IGFs) and hepatocyte growth factor (HGF), respectively, and promote signaling cascades which mediates many functions such as proliferation and protection against apoptosis, cell scattering, tumor cell motility, invasion and metastasis. In patients with metastatic colorectal cancer (mCRC), IGF1R and c-met expression confer resistance to cetuximab (monoclonal antibodies against EGFR). Therefore, the c-met and IGF1R are now an attractive novel target for anticancer therapy. In this review, we will describe correlation between two receptors and their activation effects in tumor cells, and finally introduce useful and available strategies for their targeting. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：528 / 536
页数：9
相关论文
共 50 条
[31]   MMP7 and activation of IGF1R A new insight into anti-EGFR therapeutic resistance in metastatic colorectal cancer [J].
Ohashi, Shinya ;
Natsuizaka, Mitsuteru ;
Nakagawa, Hiroshi .
CANCER BIOLOGY & THERAPY, 2011, 11 (02) :184-187
[32]   c-Met in pancreatic cancer stem cells: Therapeutic implications [J].
Herreros-Villanueva, Marta ;
Zubia-Olascoaga, Aizpea ;
Bujanda, Luis .
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (38) :5321-5323
[33]   c-Met in pancreatic cancer stem cells: Therapeutic implications [J].
Marta Herreros-Villanueva ;
Aizpea Zubia-Olascoaga ;
Luis Bujanda .
World Journal of Gastroenterology, 2012, (38) :5321-5323
[34]   Role of IGF1R in breast cancer subtypes, sternness, and lineage differentiation [J].
Farabaugh, Susan M. ;
Boone, David N. ;
Lee, Adrian V. .
FRONTIERS IN ENDOCRINOLOGY, 2015, 6
[35]   Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models [J].
Gavine, Paul R. ;
Ren, Yongxin ;
Han, Lu ;
Lu, Jing ;
Fan, Shiming ;
Zhang, Wei ;
Xu, Wen ;
Liu, Yuan Jie ;
Zhang, Tianwei ;
Fu, Haihua ;
Yu, Yongjuan ;
Wang, Huiying ;
Xu, Shirlian ;
Zhou, Feng ;
Su, Xinying ;
Yin, XiaoLu ;
Xie, Liang ;
Wang, Linfang ;
Qing, Weiguo ;
Jiao, Longxian ;
Su, Weiguo ;
Wang, Q. May .
MOLECULAR ONCOLOGY, 2015, 9 (01) :323-333
[36]   Expression of MACC1-1 and c-Met in human prostatic cancer and their clinicopathological significance [J].
Fan, Bo ;
Xu, Songtao ;
Jin, Xiaohua ;
Ding, Li .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (04) :4654-4660
[37]   IGF1R Variants Associated With Isolated Single Suture Craniosynostosis [J].
Cunningham, Michael L. ;
Horst, Jeremy A. ;
Rieder, Mark J. ;
Hing, Anne V. ;
Stanaway, Ian B. ;
Park, Sarah S. ;
Samudrala, Ram ;
Speltz, Matthew L. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2011, 155A (01) :91-97
[38]   TGF and IGF1R signaling activates protein kinase A through differential regulation of ezrin phosphorylation in colon cancer cells [J].
Leiphrakpam, Premila D. ;
Brattain, Michael G. ;
Black, Jennifer D. ;
Wang, Jing .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (21) :8242-8254
[39]   HSF4 promotes tumor progression of colorectal cancer by transactivating c-MET [J].
Wenjing Zhang ;
Xuelian Zhang ;
Peng Cheng ;
Kelin Yue ;
Ming Tang ;
Yan Li ;
Qiang Guo ;
Yu Zhang .
Molecular and Cellular Biochemistry, 2023, 478 :1141-1150
[40]   Expression of c-met proto-oncogene in primary colorectal cancer and liver metastases [J].
Fujita, S ;
Sugano, K .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (06) :378-383
12345